Free Trial

Burney Co. Boosts Stock Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Burney Co. increased its position in Genpact Limited (NYSE:G - Free Report) by 242.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 130,798 shares of the business services provider's stock after purchasing an additional 92,641 shares during the period. Burney Co. owned approximately 0.07% of Genpact worth $5,618,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of G. Advisors Asset Management Inc. grew its stake in shares of Genpact by 3.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider's stock worth $270,000 after acquiring an additional 226 shares in the last quarter. Tealwood Asset Management Inc. boosted its holdings in Genpact by 1.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider's stock worth $1,059,000 after purchasing an additional 339 shares during the last quarter. Lecap Asset Management Ltd. grew its position in Genpact by 2.1% in the 3rd quarter. Lecap Asset Management Ltd. now owns 18,059 shares of the business services provider's stock worth $708,000 after purchasing an additional 364 shares in the last quarter. Suncoast Equity Management increased its stake in Genpact by 3.1% in the 3rd quarter. Suncoast Equity Management now owns 12,600 shares of the business services provider's stock valued at $494,000 after buying an additional 375 shares during the last quarter. Finally, Sawyer & Company Inc lifted its position in shares of Genpact by 1.1% during the 3rd quarter. Sawyer & Company Inc now owns 36,243 shares of the business services provider's stock worth $1,421,000 after buying an additional 400 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Stock Performance

Shares of NYSE:G traded up $0.11 during trading on Wednesday, hitting $44.31. 1,065,061 shares of the company were exchanged, compared to its average volume of 1,293,375. The company has a market cap of $7.81 billion, a PE ratio of 12.17, a P/E/G ratio of 1.54 and a beta of 1.18. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The stock has a 50 day moving average of $44.32 and a 200 day moving average of $39.51.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 23rd. Shareholders of record on Monday, December 9th were issued a dividend of $0.1525 per share. This represents a $0.61 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date was Monday, December 9th. Genpact's payout ratio is presently 16.76%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Robert W. Baird lifted their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. TD Cowen lifted their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a report on Friday, November 8th. Finally, Needham & Company LLC upped their price objective on Genpact from $42.00 to $55.00 and gave the company a "buy" rating in a research note on Monday, November 11th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $42.33.

View Our Latest Stock Report on G

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,058 shares of company stock worth $1,558,675 over the last ninety days. Company insiders own 2.80% of the company's stock.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Analysts boosting their targets. Find out how Oracle’s cloud push is reshaping its business and driving new growth opportunities.

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines